应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03759 康龙化成
交易中 07-27 09:46:44
24.000
+0.340
+1.44%
最高
24.720
最低
23.300
成交量
125.55万
今开
23.760
昨收
23.660
日振幅
6.00%
总市值
440.40亿
流通市值
85.92亿
总股本
18.35亿
成交额
3,035万
换手率
0.35%
流通股本
3.58亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
康龙化成(300759)披露关于修订《公司章程》的公告,7月24日股价下跌1.21%
证券之星 · 07-24 22:12
康龙化成(300759)披露关于修订《公司章程》的公告,7月24日股价下跌1.21%
康龙化成通过多项资本运作授权:拟设28,000,000股H股奖励计划并获4亿美元境外发债授权
公告速递 · 07-24 21:25
康龙化成通过多项资本运作授权:拟设28,000,000股H股奖励计划并获4亿美元境外发债授权
康龙化成(03759)拟设立2800万股H股奖励计划并修订公司章程
公告速递 · 07-24 18:41
康龙化成(03759)拟设立2800万股H股奖励计划并修订公司章程
康龙化成(03759)拟采纳2026年H股奖励计划
智通财经 · 07-24 18:37
康龙化成(03759)拟采纳2026年H股奖励计划
康龙化成(300759)披露H股奖励信托计划股份归属安排,7月22日股价上涨1.02%
证券之星 · 07-22
康龙化成(300759)披露H股奖励信托计划股份归属安排,7月22日股价上涨1.02%
康龙化成转让约539.65万股库存股份 用于2025年H股奖励信托计划
公告速递 · 07-22
康龙化成转让约539.65万股库存股份 用于2025年H股奖励信托计划
康龙化成(03759.HK)转让539.65万股库存股份
智通财经 · 07-22
康龙化成(03759.HK)转让539.65万股库存股份
异动解读|康龙化成盘中上涨5.33%,半年报预告超预期叠加CRO行业订单全面回暖
行情直击 · 07-22
异动解读|康龙化成盘中上涨5.33%,半年报预告超预期叠加CRO行业订单全面回暖
张峰2026年二季度表现,农银汇理策略趋势混合基金季度涨幅7.76%
证券之星 · 07-21
张峰2026年二季度表现,农银汇理策略趋势混合基金季度涨幅7.76%
7月20日康龙化成涨5.07%,中欧医疗健康混合A基金重仓该股
证券之星 · 07-20
7月20日康龙化成涨5.07%,中欧医疗健康混合A基金重仓该股
异动解读|康龙化成盘中上涨5.69%,半年报预告超预期叠加CRO行业订单全面回暖
行情直击 · 07-20
异动解读|康龙化成盘中上涨5.69%,半年报预告超预期叠加CRO行业订单全面回暖
康龙化成获小摩增持约129.11万股 每股作价约22.11港元
新浪港股 · 07-17
康龙化成获小摩增持约129.11万股 每股作价约22.11港元
小摩增持康龙化成(03759.HK)约129.11万股 每股作价约22.11港元
智通财经 · 07-16
小摩增持康龙化成(03759.HK)约129.11万股 每股作价约22.11港元
Norges Bank减持康龙化成(03759)133.53万股 每股作价约22.86港元
智通财经 · 07-16
Norges Bank减持康龙化成(03759)133.53万股 每股作价约22.86港元
创新药连续大涨,这次真的不一样了吗?
华尔街见闻 · 07-16
创新药连续大涨,这次真的不一样了吗?
港股概念追踪 | 实验猴身价飙升至20万!多家企业反映供不应求 CRO行业订单全面回暖(附概念股)
智通财经 · 07-16
港股概念追踪 | 实验猴身价飙升至20万!多家企业反映供不应求 CRO行业订单全面回暖(附概念股)
7月15日康龙化成涨9.13%,中欧医疗健康混合A基金重仓该股
证券之星 · 07-15
7月15日康龙化成涨9.13%,中欧医疗健康混合A基金重仓该股
港股异动 | 康龙化成(03759.HK)盘中涨超11% 二季度业绩较一季度加速 订单兑现有所加快
智通财经 · 07-15
港股异动 | 康龙化成(03759.HK)盘中涨超11% 二季度业绩较一季度加速 订单兑现有所加快
异动解读|康龙化成盘中上涨6.02%,半年报预告营收增长强劲叠加CXO板块持续走强
行情直击 · 07-15
异动解读|康龙化成盘中上涨6.02%,半年报预告营收增长强劲叠加CXO板块持续走强
港股异动 | CRO概念股今日普涨 内外需求共振行业向好 机构称CXO反弹具有业绩支撑
智通财经 · 07-14
港股异动 | CRO概念股今日普涨 内外需求共振行业向好 机构称CXO反弹具有业绩支撑
加载更多
公司概况
公司名称:
康龙化成
所属市场:
SEHK
上市日期:
--
主营业务:
康龙化成(北京)新药技术股份有限公司是一家主要从事医药研发的中国公司。该公司运营五个分部。实验室服务分部主要包括实验室化学和生物科学服务,服务项目涵盖小分子化学药、寡核苷酸、多肽、抗体、抗体偶联药物和细胞与基因治疗产品等。化学和制剂工艺开发及生产服务分部包括原料药工艺开发及生产以及预制剂、制剂开发。临床研究服务分部包括国外临床研究服务和国内临床研究服务。大分子和细胞与基因治疗服务分部包括大分子药物发现及开发与生产服务和细胞与基因治疗实验室及基因治疗药物开发与生产服务。该公司还通过其他分部开展业务。
发行价格:
--
{"stockData":{"symbol":"03759","market":"HK","secType":"STK","nameCN":"康龙化成","latestPrice":24,"timestamp":1785116800595,"preClose":23.66,"halted":0,"volume":1255500,"delay":0,"changeRate":0.014370245139475903,"floatShares":358000000,"shares":1835000000,"eps":1.0883955888580437,"marketStatus":"交易中","change":0.34,"latestTime":"07-27 09:46:44","open":23.76,"high":24.72,"low":23.3,"amount":30345627,"amplitude":0.060017,"askPrice":24,"askSize":600,"bidPrice":23.94,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":1.1001949418670307,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1785124800000},"marketStatusCode":2,"adr":0,"listingDate":1574870400000,"exchange":"SEHK","adjPreClose":23.66,"dividendRate":0.009658,"openAndCloseTimeList":[[1785115800000,1785124800000],[1785128400000,1785139200000]],"volumeRatio":3.071854,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"300759","market":"SZ","secType":"STK","nameCN":"康龙化成","latestPrice":39.25,"timestamp":1785116802000,"preClose":38.53,"halted":0,"volume":24243200,"delay":0,"premium":"-47.23"}},"requestUrl":"/m/hq/s/03759","defaultTab":"news","newsList":[{"id":"2653038687","title":"康龙化成(300759)披露关于修订《公司章程》的公告,7月24日股价下跌1.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653038687","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653038687?lang=zh_cn&edition=full","pubTime":"2026-07-24 22:12","pubTimestamp":1784902344,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘,康龙化成报收于38.53元,较前一交易日下跌1.21%,最新总市值为707.91亿元。该股当日开盘38.65元,最高40.28元,最低38.18元,成交额达29.89亿元,换手率为5.39%。近日,康龙化成发布关于修订《公司章程》的公告。公告显示,公司于2026年7月24日召开第四届董事会第二次会议,审议通过修订《公司章程》的议案。修订后的章程尚需提交公司股东会审议,并授权法定代表人办理工商备案手续。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400041788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300759","03759","BK1141","BK1576","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120936219","title":"康龙化成通过多项资本运作授权:拟设28,000,000股H股奖励计划并获4亿美元境外发债授权","url":"https://stock-news.laohu8.com/highlight/detail?id=1120936219","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120936219?lang=zh_cn&edition=full","pubTime":"2026-07-24 21:25","pubTimestamp":1784899545,"startTime":"0","endTime":"0","summary":"会议审议并通过八项议案,主要内容如下:。计划规模上限为28,000,000股H股,股票来源包括二级市场回购的库存股及公司在计划项下发行的新增H股,计划有效期十年,需提交股东大会特别决议审议,并报香港联交所审核。公告显示,与各项议案相关的决议均以8票同意、0票反对、0票弃权获董事会通过。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158897096","title":"康龙化成(03759)拟设立2800万股H股奖励计划并修订公司章程","url":"https://stock-news.laohu8.com/highlight/detail?id=1158897096","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158897096?lang=zh_cn&edition=full","pubTime":"2026-07-24 18:41","pubTimestamp":1784889715,"startTime":"0","endTime":"0","summary":"2026年7月24日,康龙化成(北京)新药技术股份有限公司公告称,董事会已审议通过两项议案:一是拟采纳2026年H股奖励信托计划,二是拟对公司章程进行修订。在公司治理层面,康龙化成拟根据《上市公司章程指引》及《深圳证券交易所创业板股票上市规则》等最新法规,对现行公司章程进行修订。公司表示,关于2026年H股奖励计划及章程修订的详细信息和股东大会通告,将在可行范围内尽快向股东发出函件。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653539086","title":"康龙化成(03759)拟采纳2026年H股奖励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2653539086","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653539086?lang=zh_cn&edition=full","pubTime":"2026-07-24 18:37","pubTimestamp":1784889430,"startTime":"0","endTime":"0","summary":"董事会已决议并批准采纳2026年H股奖励计划,计划限额为2800万股H股,有关股票来源包括本公司不时回购的库存H股以及本公司不时发行的新增H股。预期2026年H股奖励计划自采纳之日起有效期为10年。2026年H股奖励计划的条款将符合《香港联合交易所有限公司证券上市规则》第17章的要求。2026年H股奖励计划须在本公司股东(股东)通过决议案,批准采纳2026年H股奖励计划后方可生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1472055.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1576","300759","03759","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653659447","title":"康龙化成(300759)披露H股奖励信托计划股份归属安排,7月22日股价上涨1.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653659447","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653659447?lang=zh_cn&edition=full","pubTime":"2026-07-22 22:03","pubTimestamp":1784728996,"startTime":"0","endTime":"0","summary":"截至2026年7月22日收盘,康龙化成报收于39.76元,较前一交易日上涨1.02%,最新总市值为730.5亿元。该股当日开盘38.4元,最高41.04元,最低37.65元,成交额达45.31亿元,换手率为8.0%。近日,康龙化成(北京)新药技术股份有限公司提交翌日披露报表,显示因转让库存股份予公司受托人,为2025年H股奖励信托计划项下股份奖励归属作准备,H股已发行股份增加5,396,470股,占事件前已发行股份的1.53%。本次变动后,已发行H股总数维持359,977,887股不变。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200047131.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03759","300759","BK1141","BK1576","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127898740","title":"康龙化成转让约539.65万股库存股份 用于2025年H股奖励信托计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1127898740","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127898740?lang=zh_cn&edition=full","pubTime":"2026-07-22 16:42","pubTimestamp":1784709724,"startTime":"0","endTime":"0","summary":"康龙化成(北京)新药技术股份有限公司(股票代码:03759)于2026年7月22日发布公告,披露当日将公司约5,396,470股库存股份(占调整前已发行股本的1.53%)转让予受托人,用于已采纳的2025年H股奖励信托计划所授出的股份奖励归属之准备。转让价格为每股0港元。\n该次变动完成后,公司已发行股本(不含库存股份)增至358,111,057股,库存股份数则相应降至1,866,830股,总发行股份数仍为359,977,887股。公司表示,该转让事宜已获董事会正式授权并已遵循香港联合交易所有限公司证券上市规则及有关法律法规的要求。公告由公司秘书麦宝文签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"康龙化成转让约539.65万股库存股份 用于2025年H股奖励信托计划","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653753355","title":"康龙化成(03759.HK)转让539.65万股库存股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2653753355","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653753355?lang=zh_cn&edition=full","pubTime":"2026-07-22 16:39","pubTimestamp":1784709582,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1141","BK1576","03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142423927","title":"异动解读|康龙化成盘中上涨5.33%,半年报预告超预期叠加CRO行业订单全面回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=1142423927","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142423927?lang=zh_cn&edition=full","pubTime":"2026-07-22 09:48","pubTimestamp":1784684929,"startTime":"0","endTime":"0","summary":"7月22日,康龙化成盘中上涨5.33%,报24.8港元,成交额7282.08万港元。消息面上,公司此前披露半年度业绩预告,预计上半年营收74.72亿至76.65亿元,同比增长16%-19%;归母净利润7.29亿至7.72亿元,同比增长4%-10%。值得关注的是,新签订单同比增长超30%,其中小分子CDMO新签订单同比增长超50%,二季度业绩较一季度明显加速。行业层面,CRO板块订单全面回暖,头部企业在手订单同比增长超40%,机构认为CXO反弹具有业绩支撑。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653209208","title":"张峰2026年二季度表现,农银汇理策略趋势混合基金季度涨幅7.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653209208","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653209208?lang=zh_cn&edition=full","pubTime":"2026-07-21 23:48","pubTimestamp":1784648935,"startTime":"0","endTime":"0","summary":"证券之星消息,截止2026年二季度末,基金经理张峰旗下共管理4只基金,本季度表现最佳的为农银汇理策略趋势混合,季度净值涨7.76%。持有期间的估算收益率为163.7%,持有期间广联达在2019年到2020年的年报归属净利润增幅达40.55%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100046026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","03759","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652296747","title":"7月20日康龙化成涨5.07%,中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652296747","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652296747?lang=zh_cn&edition=full","pubTime":"2026-07-20 16:49","pubTimestamp":1784537340,"startTime":"0","endTime":"0","summary":"证券之星消息,7月20日康龙化成涨5.07%,收盘报37.28元,换手率8.51%,成交量120.81万手,成交额44.43亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共69家,其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为129.74亿元,最新净值1.926,较上一交易日下跌7.65%,近一年上涨2.86%。中欧医疗健康混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000025158.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03759","BK1141","159760","300759","BK0216","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141509720","title":"异动解读|康龙化成盘中上涨5.69%,半年报预告超预期叠加CRO行业订单全面回暖","url":"https://stock-news.laohu8.com/highlight/detail?id=1141509720","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141509720?lang=zh_cn&edition=full","pubTime":"2026-07-20 10:02","pubTimestamp":1784512938,"startTime":"0","endTime":"0","summary":"7月20日,康龙化成盘中上涨5.69%,报24.4港元,成交额7271.42万港元。消息面上,公司此前披露半年度业绩预告,预计上半年营收74.72亿至76.65亿元,同比增长16%-19%;归母净利润7.29亿至7.72亿元,同比增长4%-10%。值得关注的是,新签订单同比增长超30%,其中小分子CDMO新签订单同比增长超50%,二季度业绩较一季度明显加速。行业层面,CRO板块订单全面回暖,头部企业在手订单同比增长超40%,机构认为CXO反弹具有业绩支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652247841","title":"康龙化成获小摩增持约129.11万股 每股作价约22.11港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652247841","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652247841?lang=zh_cn&edition=full","pubTime":"2026-07-17 08:09","pubTimestamp":1784246940,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 香港联交所最新资料显示,7月10日,小摩增持康龙化成(03759)129.114万股,每股作价22.1068港元,总金额约为2854.3万港元。增持后最新持股数目约为2638.28万股,最新持股比例为7.32%。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-07-17/doc-iniiahrh7412772.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["EWH","300759","LU0187121727.USD","IE00B1BXHZ80.USD","LU0345770308.USD","LU1261432733.SGD","LU1670628061.USD","LU2505996509.AUD","LU0203347892.USD","LU2264538146.SGD","IE00BFXG1179.USD","LU0417517546.SGD","IYG","SG9999002232.USD","IYF","LU2417539215.USD","VFH","LU2746668461.USD","LU1496350502.SGD","JPX","LU0006306889.USD","LU2462157665.USD","UYG","FNCL","KBWB","FTXO","BK1141","LU2430703178.SGD","LU0106831901.USD","LU1244550221.USD","LU1917777945.USD","LU0267386448.USD","LU0170899867.USD","BK4566","LU1267930490.SGD","IE00BJLML261.HKD","JPO","LU0265550946.USD","XLF","IXG","LU0820561909.HKD","LU1244550494.USD","LU0238689110.USD","IE00B1XK9C88.USD","LU0787776722.HKD","LU2023250330.USD","JPMO","LU1720051017.SGD","BK4581","03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651285449","title":"小摩增持康龙化成(03759.HK)约129.11万股 每股作价约22.11港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651285449","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651285449?lang=zh_cn&edition=full","pubTime":"2026-07-16 19:33","pubTimestamp":1784201618,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1576","BK1141","03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651970449","title":"Norges Bank减持康龙化成(03759)133.53万股 每股作价约22.86港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651970449","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651970449?lang=zh_cn&edition=full","pubTime":"2026-07-16 19:14","pubTimestamp":1784200448,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新数据显示,7月14日,Norges Bank减持康龙化成(03759)133.53万股,每股作价22.8609港元,总金额约为3052.62万港元。减持后最新持股数目约为2443.48万股,持股比例为6.93%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1468579.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","ENOR","BK0216","EWH","03759","BK1576","300759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651341039","title":"创新药连续大涨,这次真的不一样了吗?","url":"https://stock-news.laohu8.com/highlight/detail?id=2651341039","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651341039?lang=zh_cn&edition=full","pubTime":"2026-07-16 17:05","pubTimestamp":1784192720,"startTime":"0","endTime":"0","summary":"政策上,医保初审通过率创新高,定价机制优化,并建立“医保+商保”双层支付体系;产业上,上半年BD交易总额达1100亿美元,国际竞争力显著提升;资金面上,内外资持续回流。行业正从“讲故事”转向盈利兑现,国金证券认为,2027年有望成为中国创新药海外商业化集中兑现的重要节点。","market":"hk","thumbnail":"https://static.tigerbbs.com/8daedf52c02cecfd417dcbd813afb3fa","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8daedf52c02cecfd417dcbd813afb3fa"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3777107","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","06978","06618","09606","BK1574","01672","06996","09995","06622","09966","02359","02137","IBBQ","09688","03759","159992","01801","00241","03347","06606","02269","BK1161","02268"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2651945934","title":"港股概念追踪 | 实验猴身价飙升至20万!多家企业反映供不应求 CRO行业订单全面回暖(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651945934","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651945934?lang=zh_cn&edition=full","pubTime":"2026-07-16 07:49","pubTimestamp":1784159344,"startTime":"0","endTime":"0","summary":"当前,整个CRO行业正处于订单全面回暖的上行期。药明康德、康龙化成、益诺思、昭衍新药等多家头部CRO企业2026年一季度新签订单普遍实现大幅增长。截至一季度末,在手订单约31亿元,同比增长40.9%。对于2026年,药明康德此前预计,2026全年整体收入达513亿元至530亿元;持续经营业务收入同比增长18%至22%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1468210.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","SG9999002463.SGD","LU0708995583.HKD","LU0456846285.SGD","LU0052750758.USD","LU0516422366.SGD","LU0043850808.USD","LU0516423174.USD","BK4588","06127","LU0823426480.USD","LU0516422952.EUR","LU0456827905.SGD","LU3063872942.SGD","LU2045819591.USD","02269","LU0140636845.USD","LU0819121731.USD","LU0181495838.USD","LU0979878070.USD","LU1720050803.USD","IE00B0JY6N72.USD","BK1610","SG9999002562.SGD","LU0359202008.SGD","LU0823426308.USD","LU1880383366.USD","KCAI","LU0348825331.USD","LU0572944931.SGD","LU0359201612.USD","BK1589","03759","LU0326950275.SGD","VXUS","KURE","LU0320764599.SGD","BK1521","LU0417516902.SGD","LU0348766576.USD","BK1576","LU1046422090.SGD","LU1794554557.SGD","LU0856984785.SGD","LU0039217434.USD","LU0348767384.USD","LU1242518857.USD","BK1141","LU0307460666.USD","02359"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651545587","title":"7月15日康龙化成涨9.13%,中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651545587","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651545587?lang=zh_cn&edition=full","pubTime":"2026-07-15 16:36","pubTimestamp":1784104563,"startTime":"0","endTime":"0","summary":"证券之星消息,7月15日康龙化成涨9.13%创60日新高,收盘报40.3元,换手率11.4%,成交量161.86万手,成交额64.21亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共69家,其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为129.74亿元,最新净值2.002,较上一交易日上涨3.85%,近一年上涨11.19%。中欧医疗健康混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500031208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03759","159760","BK0216","300759","BK1576","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651434274","title":"港股异动 | 康龙化成(03759.HK)盘中涨超11% 二季度业绩较一季度加速 订单兑现有所加快","url":"https://stock-news.laohu8.com/highlight/detail?id=2651434274","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651434274?lang=zh_cn&edition=full","pubTime":"2026-07-15 14:10","pubTimestamp":1784095846,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["03759","BK1576","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187193050","title":"异动解读|康龙化成盘中上涨6.02%,半年报预告营收增长强劲叠加CXO板块持续走强","url":"https://stock-news.laohu8.com/highlight/detail?id=1187193050","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187193050?lang=zh_cn&edition=full","pubTime":"2026-07-15 09:46","pubTimestamp":1784079963,"startTime":"0","endTime":"0","summary":"7月15日,康龙化成盘中上涨6.02%,报24.74港元,成交额1.22亿港元。新签订单同比增长超过30%,其中小分子CDMO服务新签订单同比增长超过50%,Q2营收同比增长19.38%,盈利环比显著提速。行业层面,CXO板块在业绩和订单支撑下持续反弹,CRO指数自6月8日至7月10日已累计反弹21.72%,机构认为随着中期业绩临近,CXO反弹有望获得业绩支撑。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651272331","title":"港股异动 | CRO概念股今日普涨 内外需求共振行业向好 机构称CXO反弹具有业绩支撑","url":"https://stock-news.laohu8.com/highlight/detail?id=2651272331","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651272331?lang=zh_cn&edition=full","pubTime":"2026-07-14 14:48","pubTimestamp":1784011706,"startTime":"0","endTime":"0","summary":"据报道称,当前食蟹猴身价已突破20万元。华鑫证券研报认为,从6月初至今,CXO板块在业绩和订单的支撑下,率先于创新药反弹。自6月8日至7月10日,CRO指数已反弹21.72%。展望下半年,创新药融资增长将继续支持CXO景气度延续。目前CRO龙头企业药明康德2027年预测PE为17.58X,凯莱英为33.19X。随着中期业绩临近,2季度订单趋势逐步明确,CXO反弹有望获得业绩支撑。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1467104.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","LU0052750758.USD","LU2242644610.SGD","LU0708995583.HKD","BK4588","LU1046422090.SGD","BK1141","02359","KCAI","VXUS","BK4585","LU0348767384.USD","CXO","03759","BK1583","06821","LU2045819591.USD","06127","LU0348766576.USD","LU2125910500.SGD","BK1576","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pharmaron.com","stockEarnings":[{"period":"1week","weight":0.0198},{"period":"1month","weight":0.4697},{"period":"3month","weight":0.1615},{"period":"6month","weight":0.115},{"period":"1year","weight":0.1531},{"period":"ytd","weight":0.2214}],"compareEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":0.0662},{"period":"3month","weight":-0.0391},{"period":"6month","weight":-0.0668},{"period":"1year","weight":-0.0274},{"period":"ytd","weight":-0.026}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康龙化成(北京)新药技术股份有限公司是一家主要从事医药研发的中国公司。该公司运营五个分部。实验室服务分部主要包括实验室化学和生物科学服务,服务项目涵盖小分子化学药、寡核苷酸、多肽、抗体、抗体偶联药物和细胞与基因治疗产品等。化学和制剂工艺开发及生产服务分部包括原料药工艺开发及生产以及预制剂、制剂开发。临床研究服务分部包括国外临床研究服务和国内临床研究服务。大分子和细胞与基因治疗服务分部包括大分子药物发现及开发与生产服务和细胞与基因治疗实验室及基因治疗药物开发与生产服务。该公司还通过其他分部开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":-0.020006},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.034007},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.039454},{"month":4,"riseRate":0.857143,"avgChangeRate":0.052246},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.006682},{"month":6,"riseRate":0.714286,"avgChangeRate":0.071007},{"month":7,"riseRate":0.714286,"avgChangeRate":0.114072},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.03236},{"month":9,"riseRate":0.666667,"avgChangeRate":0.13402},{"month":10,"riseRate":0.5,"avgChangeRate":-0.053123},{"month":11,"riseRate":0.333333,"avgChangeRate":0.036146},{"month":12,"riseRate":0.571429,"avgChangeRate":0.025859}],"exchange":"SEHK","name":"康龙化成","nameEN":"PHARMARON"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康龙化成(03759)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康龙化成(03759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康龙化成,03759,康龙化成股票,康龙化成股票老虎,康龙化成股票老虎国际,康龙化成行情,康龙化成股票行情,康龙化成股价,康龙化成股市,康龙化成股票价格,康龙化成股票交易,康龙化成股票购买,康龙化成股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康龙化成(03759)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康龙化成(03759)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}